Archive
CTO Revoked
![]() | |||||||||
![]() | ![]() | ![]() |
Vancouver, British Columbia / TheNewswire / August 8, 2017 – AREV Nutrition Sciences Inc. ("AREV" or the “Company”) (CNSX - ARV), is pleased to advise that the Alberta, British Columbia and Ontario Securities Commissions have revoked their Cease Trade Orders against the Corporation as of August 2, 2017. The Cease Trade Orders were issued as a result of the Corporation’s failure to file its audited annual year-end financial statements for the period ended December 31, 2016 and interim financial statements for the period ended March 31, 2017 on time.
The Financial Statements, the MD&A and the Certificates are all now available under the Company’s profile on SEDAR at www.sedar.com.
For further information, contact Stephane Maher, CEO at stephane@arevnutrition.com.
On behalf of the Board,
Stephane Maher
Chief Executive Officer & Director
About AREV Nutrition Sciences Inc.
AREV Nutrition Sciences Inc. (“AREV”), produces and delivers functional ingredients from its world-class extraction system. AREV is revolutionizing the current delivery method of coconut oil, whey protein and nutrients through emulsification. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. AREV is also working with Pharmacy and Dispensary operators with an innovative emulsified base formula to disperse Cannabis oil extracts.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
FORWARD LOOKING INFORMATION
This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s Discussion and Analysis under the Company’s profile on www.sedar.com.